Skip to main content

Table 3 L-T4 dosages in patients who achieved and did not achieve target serum TSH levels

From: A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)

Parameter

All

Patients who achieved serum TSH target

Patients who did not achieve serum TSH target

p valuea

LT-4 dosage, μg/d, Median (Range)

(N = 1618)

100.00 (41.20–200.00)

100.00 (48.05–194.45)

100.00 (41.20–200.00)

0.6026

LT-4 dosage, μg//kg/d, Median (Range)

(N = 1613)

1.65 (0.51–3.70)

1.69 (0.67–3.36)

1.58 (0.51–3.70)

<  0.0001

  1. aPatients who did not achieve serum TSH target vs. patients who achieved serum TSH target
  2. LT-4 levothyroxine, TSH thyroid stimulating hormone
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us